PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Niclosamide→

Niclosamide PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
50-65-7
Molecular formula
C13H8Cl2N2O4
Molecular weight
327.12 g/mol
Drug class
Salicylanilide anthelminticcestocidal agent
Mechanism of action
Interferes with mitochondrial energy metabolism and oxidative phosphorylation in cestodes, disrupting ATP production and causing death of the parasite. It is poorly absorbed from the gastrointestinal tract.
Indications / reported uses
  • Treatment of intestinal tapeworm infections (taeniasis) caused by susceptible cestodes in countries where oral niclosamide is authorised; it is not a treatment for tissue-invasive larval tapeworm disease

Sources: WHO Model List / essential medicines information — Niclosamide · NLM MeSH — Niclosamide · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Niclosamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Niclosamide Permitted Daily Exposure (PDE) report (the Niclosamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Niclosamide Occupational Exposure Limit (OEL) report (the Niclosamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.